Aldosterone-to-renin ratio is related to arterial stiffness when the screening criteria of primary aldosteronism are not met

被引:0
作者
Eeva Kokko
Pasi I. Nevalainen
Manoj Kumar Choudhary
Jenni Koskela
Antti Tikkakoski
Heini Huhtala
Onni Niemelä
Marianna Viukari
Jukka Mustonen
Niina Matikainen
Ilkka Pörsti
机构
[1] Tampere University,Faculty of Medicine and Health Technology
[2] Tampere University Hospital,Department of Internal Medicine
[3] Tampere University Hospital,Department of Clinical Physiology
[4] Tampere University,Faculty of Social Sciences
[5] Seinäjoki Central Hospital,Clinical Laboratory and Medical Research Unit
[6] University of Helsinki,Endocrinology, Helsinki University Hospital and Research Programs Unit, Clinical and Molecular Medicine
来源
Scientific Reports | / 10卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Aldosterone-to-renin ratio (ARR) is a screening tool for primary aldosteronism (PA), but the significance of ARR when the PA criteria are not met remains largely unknown. In this cross-sectional study we investigated the association of ARR with haemodynamic variables in 545 normotensive and never-medicated hypertensive subjects (267 men, 278 women, age range 19–72 years) without suspicion of PA. Supine haemodynamic data was recorded using whole-body impedance cardiography and radial tonometric pulse wave analysis. In sex-adjusted quartiles of ARR, determined as serum aldosterone to plasma renin activity ratio, the mean values were 282, 504, 744 and 1467 pmol/µg of angiotensin I/h, respectively. The only difference in haemodynamic variables between the ARR quartiles was higher pulse wave velocity (PWV) in the highest quartile versus other quartiles (p = 0.004), while no differences in blood pressure (BP), heart rate, wave reflections, cardiac output or systemic vascular resistance were observed between the quartiles. In linear regression analysis with stepwise elimination, ARR was an independent explanatory factor for PWV (β = 0.146, p < 0.001, R2 of the model 0.634). In conclusion, ARR was directly and independently associated with large arterial stiffness in individuals without clinical suspicion of PA. Therefore, ARR could serve as a clinical marker of cardiovascular risk.
引用
收藏
相关论文
共 106 条
[1]  
Young WF(2019)Diagnosis and treatment of primary aldosteronism: practical clinical perspectives J. Intern. Med. 285 126-148
[2]  
Mulatero P(2016)Guidelines for primary aldosteronism: uptake by primary care physicians in europe J. Hypertens. 34 2253-2257
[3]  
Rossi E(2017)Diagnostic rate of primary aldosteronism in emilia-romagna, Northern Italy, during 16 years (2000–2015) J. Hypertens. 35 1691-1697
[4]  
Perazzoli F(2012)Prevalence of primary aldosteronism in patient’s cohorts and in population-based studies—a review of the current literature Horm. Metab. Res. 44 157-162
[5]  
Negro A(2016)The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society clinical practice guideline J. Clin. Endocrinol. Metab. 101 1889-1916
[6]  
Magnani A(2017)Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice J. Am. Coll. Cardiol. 69 1811-1820
[7]  
Hannemann A(2020)The unrecognized prevalence of primary aldosteronism: a cross-sectional study Ann. Intern. Med. 173 10-20
[8]  
Wallaschofski H(2005)Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism J. Am. Coll. Cardiol. 45 1243-1248
[9]  
Funder JW(2018)Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis Lancet Diabetes Endocrinol. 6 41-50
[10]  
Monticone S(2007)Aldosterone and end-organ damage Clin. Sci. 113 267-278